Development of the implantable transvenous cardioverter

Douglas P. Zipes, James J. Heger, William M. Miles, Eric N. Prystowsky

Research output: Contribution to journalArticle

Abstract

The development of the transvenous cardioverter, from the initial animal studies, to the clinical studies using temporary leads, to the initial permanent implants is described. Shocks ≤2.0 joules synchronized to the QRS complex and delivered through a specially designed catheter electrode placed in the apex of the right ventricle successfully terminate most episodes of ventricular tachycardia in patients. The implanted unit which also serves as a demand ventricular pacemaker, can be used to perform programmed electrophysiologic studies. Future devices must be capable of defibrillation and more accurate arrhythmia detection.

Original languageEnglish (US)
Pages (from-to)67D-72D
JournalThe American journal of cardiology
Volume54
Issue number9
DOIs
StatePublished - 1984

Fingerprint

Ventricular Tachycardia
Heart Ventricles
Cardiac Arrhythmias
Shock
Electrodes
Catheters
Equipment and Supplies
Clinical Studies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Zipes, D. P., Heger, J. J., Miles, W. M., & Prystowsky, E. N. (1984). Development of the implantable transvenous cardioverter. The American journal of cardiology, 54(9), 67D-72D. https://doi.org/10.1016/S0002-9149(84)80289-1

Development of the implantable transvenous cardioverter. / Zipes, Douglas P.; Heger, James J.; Miles, William M.; Prystowsky, Eric N.

In: The American journal of cardiology, Vol. 54, No. 9, 1984, p. 67D-72D.

Research output: Contribution to journalArticle

Zipes, DP, Heger, JJ, Miles, WM & Prystowsky, EN 1984, 'Development of the implantable transvenous cardioverter', The American journal of cardiology, vol. 54, no. 9, pp. 67D-72D. https://doi.org/10.1016/S0002-9149(84)80289-1
Zipes, Douglas P. ; Heger, James J. ; Miles, William M. ; Prystowsky, Eric N. / Development of the implantable transvenous cardioverter. In: The American journal of cardiology. 1984 ; Vol. 54, No. 9. pp. 67D-72D.
@article{ba29fff39b0543b5850a00ae30705364,
title = "Development of the implantable transvenous cardioverter",
abstract = "The development of the transvenous cardioverter, from the initial animal studies, to the clinical studies using temporary leads, to the initial permanent implants is described. Shocks ≤2.0 joules synchronized to the QRS complex and delivered through a specially designed catheter electrode placed in the apex of the right ventricle successfully terminate most episodes of ventricular tachycardia in patients. The implanted unit which also serves as a demand ventricular pacemaker, can be used to perform programmed electrophysiologic studies. Future devices must be capable of defibrillation and more accurate arrhythmia detection.",
author = "Zipes, {Douglas P.} and Heger, {James J.} and Miles, {William M.} and Prystowsky, {Eric N.}",
year = "1984",
doi = "10.1016/S0002-9149(84)80289-1",
language = "English (US)",
volume = "54",
pages = "67D--72D",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Development of the implantable transvenous cardioverter

AU - Zipes, Douglas P.

AU - Heger, James J.

AU - Miles, William M.

AU - Prystowsky, Eric N.

PY - 1984

Y1 - 1984

N2 - The development of the transvenous cardioverter, from the initial animal studies, to the clinical studies using temporary leads, to the initial permanent implants is described. Shocks ≤2.0 joules synchronized to the QRS complex and delivered through a specially designed catheter electrode placed in the apex of the right ventricle successfully terminate most episodes of ventricular tachycardia in patients. The implanted unit which also serves as a demand ventricular pacemaker, can be used to perform programmed electrophysiologic studies. Future devices must be capable of defibrillation and more accurate arrhythmia detection.

AB - The development of the transvenous cardioverter, from the initial animal studies, to the clinical studies using temporary leads, to the initial permanent implants is described. Shocks ≤2.0 joules synchronized to the QRS complex and delivered through a specially designed catheter electrode placed in the apex of the right ventricle successfully terminate most episodes of ventricular tachycardia in patients. The implanted unit which also serves as a demand ventricular pacemaker, can be used to perform programmed electrophysiologic studies. Future devices must be capable of defibrillation and more accurate arrhythmia detection.

UR - http://www.scopus.com/inward/record.url?scp=0021718041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021718041&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(84)80289-1

DO - 10.1016/S0002-9149(84)80289-1

M3 - Article

C2 - 6496370

AN - SCOPUS:0021718041

VL - 54

SP - 67D-72D

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 9

ER -